Back to all papers

Fully Automated, Explainable AI Analysis of Coronary CTA Improves Prediction of Major Cardiovascular Events.

November 19, 2026pubmed logopapers

Authors

Gulsun MA,Singh V,Lira J,Sami S,Gupta P,Agarwal S,O'Donnell TP,Laidlaw M,Shaw RE,Sharma P,Gupta H

Affiliations (3)

  • Siemens Healthineers, Princeton, New Jersey, USA.
  • Valley Health System, Paramus, New Jersey, USA.
  • Valley Health System, Paramus, New Jersey, USA. Electronic address: [email protected].

Abstract

Coronary artery disease (CAD) remains a major global cause of morbidity and mortality. Coronary computed tomography angiography (CCTA) is central to noninvasive diagnosis and risk assessment, yet current workflows are labor-intensive and depend on semiquantitative scoring systems that do not fully leverage prognostic information in CCTA. The objectives of the study were to develop and validate a fully automated, explainable artificial intelligence (AI) system (AI-automated coronary analysis [ACA]) for comprehensive CCTA analysis to predict major adverse cardiovascular events and compare its performance with conventional risk markers. AI-ACA automatically extracts a suite of CCTA-derived biomarkers, including stenosis severity, plaque burden, and composition; AI-derived CAD - reporting and data system (CAD-RADS) (AI-CADRADS); coronary tortuosity; and subtended myocardial mass, to generate interpretable risk estimates. In a retrospective cohort (n = 1,702), we compared AI-ACA with Agatston score, standard demographic risk markers, and AI-CADRADS. Model explainability was assessed using Shapley Additive Explanations. AI-ACA demonstrated higher predictive performance (area under the curve [AUC]: 0.81) than Agatston score (AUC: 0.76) and demographic markers (AUC: 0.67), and similar performance to AI-CADRADS (AUC: 0.81). AI-ACA showed better prognostic discrimination than Agatston score, reflected by a higher Harrell C-index (0.791 vs 0.742) and greater separation in event-free survival on Kaplan-Meier analysis (log-rank 31.79 vs 13.71). Shapley Additive Explanations analysis identified total plaque volume and burden, maximum stenosis severity, and AI-CADRADS as the strongest contributors to risk estimation. A fully automated and explainable AI platform for CCTA enables comprehensive quantitative characterization of CAD without manual intervention. Although prognostic performance was comparable to AI-CADRADS and modestly higher than Agatston score, the platform provides transparent biomarker-based risk assessment and scalable analysis that may facilitate broader clinical implementation of quantitative CCTA.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.